NCT00058149

Clinical Trial Information


Trial Number: NCT00058149 (ClinicalTrials.gov)
Disease Type:
  • Gastrointestinal Neoplasm - Pancreatic Cancer (excluding Islets)
Trial Title:
A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma
Study ID:
E6201
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®